Current Vascular Pharmacology
Title:Meet Our Section Editor
Volume: 16 Issue: 6
Author(s): Demosthenes B. Panagiotakos
Affiliation:
Export Options
About this article
Cite this article as:
Panagiotakos B. Demosthenes , Meet Our Section Editor, Current Vascular Pharmacology 2018; 16 (6) . https://dx.doi.org/10.2174/157016111606180910164838
DOI https://dx.doi.org/10.2174/157016111606180910164838 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
15
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Subtype-Selective Noncompetitive Modulators of Metabotropic Glutamate Receptor Subtype 1 (mGluR1)
Current Topics in Medicinal Chemistry Milestones in Antihypertensive Drug Treatment
Current Pharmaceutical Design Dry Eyes in Rheumatic Disease
Current Rheumatology Reviews The Glial Sodium-Calcium Exchanger: A New Target for Nitric Oxide- Mediated Cellular Toxicity
Current Protein & Peptide Science COX-2: Friend or Foe?
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Medical Imaging High Prevalence of Cerebral Microbleeds in Young Ischemic Stroke Patients
Current Neurovascular Research Kinase Inhibitors Involved in the Regulation of Autophagy: Molecular Concepts and Clinical Implications
Current Medicinal Chemistry Reduction in the Ratio of Low-density Lipoprotein Cholesterol to Highdensity Lipoprotein Cholesterol is Associated with Increased Risks of Hemorrhagic Transformation in Patients with Acute Ischemic Stroke
Current Neurovascular Research Targeting Conserved Pathways: Mitochondrial Dysfunction and Beyond
Current Neurovascular Research Alzheimers Disease, Ceramide, Visfatin and NAD
CNS & Neurological Disorders - Drug Targets Group II Secretory PLA2: A New Cardiovascular Risk Factor
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Lipoprotein(a) Management: Pharmacological and Apheretic Treatment
Current Medicinal Chemistry Editorial: Statins and Tissue Plasminogen Activator for Stroke: A Beneficial Combination?
Current Vascular Pharmacology Type 3 Diabetes Mellitus: A Novel Implication of Alzheimers Disease
Current Topics in Medicinal Chemistry A Comprehensive Review on Pellets as a Dosage Form in Pharmaceuticals
Current Drug Targets Patent Selections
Recent Patents on DNA & Gene Sequences Adult Neural Stem Cell Therapy: Expansion In Vitro, Tracking In Vivo and Clinical Transplantation
Current Drug Targets Chemokines in Cardiovascular Remodeling: Clinical and Therapeutic Implications
Current Molecular Medicine Neural Stem Cell Transplantation and CNS Diseases
CNS & Neurological Disorders - Drug Targets